Business Description
Basel Medical Group Ltd
ISIN : VGG0864B1031
Total Employee Number:
77Description
Basel Medical Group Ltd provides general and subspecialized orthopedic, trauma and sports medicine services such as knee/hip replacements, sports medicine/surgery, spine surgery, foot/ankle surgery and minimally invasive orthopedic procedures, as well as neurosurgical treatments. The services provided by clinics include, but are not limited to, consultation, medical diagnosis and medical or surgical treatments for orthopedic, trauma, sports medicine, general practice, health screening, mental health, women's health and neurosurgical conditions and clinics are equipped with the facilities needed to perform a variety of procedures on site and minor surgical services. Key revenue is generated from Singapore.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.15 | |||||
Equity-to-Asset | 0.31 | |||||
Debt-to-Equity | 1.43 | |||||
Debt-to-EBITDA | -1.24 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | -0.84 | |||||
Beneish M-Score | -2.55 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -0.3 | |||||
3-Year Book Growth Rate | 15.9 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 42.15 | |||||
9-Day RSI | 44.1 | |||||
14-Day RSI | 45.06 | |||||
3-1 Month Momentum % | 1.5 | |||||
6-1 Month Momentum % | -26.63 | |||||
12-1 Month Momentum % | -76.21 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.88 | |||||
Quick Ratio | 1.84 | |||||
Cash Ratio | 0.18 | |||||
Days Inventory | 31.56 | |||||
Days Sales Outstanding | 56.35 | |||||
Days Payable | 160.18 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -0.6 | |||||
Shareholder Yield % | -23.46 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 75.72 | |||||
Operating Margin % | -30.92 | |||||
Net Margin % | -69.33 | |||||
EBITDA Margin % | -49.72 | |||||
FCF Margin % | -8.09 | |||||
OCF Margin % | -4.54 | |||||
ROE % | -162.38 | |||||
ROA % | -57.05 | |||||
ROIC % | -49.45 | |||||
3-Year ROIIC % | 96.12 | |||||
ROC (Joel Greenblatt) % | -130.13 | |||||
ROCE % | -108.26 | |||||
Years of Profitability over Past 10-Year | 3 | |||||
Moat Score | 2 | |||||
Tariff Resilience Score | 5 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 0.85 | |||||
PB Ratio | 1.97 | |||||
Price-to-Tangible-Book | 1.97 | |||||
EV-to-EBIT | -2 | |||||
EV-to-EBITDA | -2.79 | |||||
EV-to-Revenue | 1.39 | |||||
EV-to-FCF | -17.16 | |||||
| Price-to-Net-Current-Asset-Value | 38.38 | |||||
Earnings Yield (Greenblatt) % | -50 | |||||
FCF Yield % | -9.52 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:BMGL
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Basel Medical Group Ltd Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 11.305 | ||
| EPS (TTM) ($) | -5.046 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 86.64 | ||
| 14-Day RSI | 45.06 | ||
| 14-Day ATR ($) | 1.325212 | ||
| 20-Day SMA ($) | 6.955495 | ||
| 12-1 Month Momentum % | -76.21 | ||
| 52-Week Range ($) | 4.596 - 36.6 | ||
| Shares Outstanding (Mil) | 1.57 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Basel Medical Group Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Basel Medical Group Ltd Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Annual report for 2026 | 2026-11-18 | In 125 days | ||
| First quarter earnings results for 2027 | 2026-11-18 | In 125 days | ||
| Fourth quarter earnings results for 2026 | 2026-08-12 | In 27 days | ||
| General meeting for 2025 | 2026-07-21 | In 5 days | ||
| Third quarter earnings results for 2026 | 2026-07-15 | 6.14 (-5.54%) | ||
| 0.0833333:1 Stock Split | 2026-06-22 | 7.41 (+11.29%) | ||
| Annual report for 2025 | 2025-11-18 | 13.44 (-4.27%) |
Show
Entries
Basel Medical Group Ltd Frequently Asked Questions
What is Basel Medical Group Ltd(BMGL)'s stock price today?
The current price of BMGL is $6.14. The 52 week high of BMGL is $36.60 and 52 week low is $4.60.
When is next earnings date of Basel Medical Group Ltd(BMGL)?
The next earnings date of Basel Medical Group Ltd(BMGL) is 2026-08-12 Est..
Does Basel Medical Group Ltd(BMGL) pay dividends? If so, how much?
Basel Medical Group Ltd(BMGL) does not pay dividend.
Guru Commentaries on NAS:BMGL
No articles.
Press Release
Articles on Basel Medical Group Ltd
Headlines
See More- 1
Jul 10, 2026
Basel Medical regains compliance with Nasdaq minimum bid price rule
Seeking Alpha • 6:09am
- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers